{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T04:34:21Z","timestamp":1791261261932,"version":"4.1.0"},"reference-count":63,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T00:00:00Z","timestamp":1786320000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001700","name":"Government of Japan Ministry of Education Culture Sports Science and Technology","doi-asserted-by":"publisher","award":["23H00552"],"award-info":[{"award-number":["23H00552"]}],"id":[{"id":"10.13039\/501100001700","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["JP25ama121052"],"award-info":[{"award-number":["JP25ama121052"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Therapy Nucleic Acids"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.omtn.2026.103057","type":"journal-article","created":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T23:28:44Z","timestamp":1786577324000},"page":"103057","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Adenovirus vector-mediated delivery of the CRISPR-CasRx system enables gene knockdown with suppressed collateral activity"],"prefix":"10.1016","volume":"37","author":[{"given":"Yuki","family":"Osakada","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sota","family":"Kidawara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eiko","family":"Sakai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akira","family":"Asayama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fuminori","family":"Sakurai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kahori","family":"Shimizu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0594-8178","authenticated-orcid":false,"given":"Hiroyuki","family":"Mizuguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.omtn.2026.103057_bib1","first-page":"1709","article-title":"CRISPR provides acquired resistance against viruses in prokaryotes","volume":"315","author":"Barrangou","year":"2007","journal-title":"Science"},{"key":"10.1016\/j.omtn.2026.103057_bib2","first-page":"819","article-title":"Multiplex genome engineering using CRISPR\/Cas systems","volume":"339","author":"Cong","year":"2013","journal-title":"Science"},{"key":"10.1016\/j.omtn.2026.103057_bib3","first-page":"823","article-title":"RNA-guided human genome engineering via Cas9","volume":"339","author":"Mali","year":"2013","journal-title":"Science"},{"key":"10.1016\/j.omtn.2026.103057_bib4","first-page":"551","article-title":"Genome editing with Cas9 in adult mice corrects a disease mutation and phenotype","volume":"32","author":"Yin","year":"2014","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.omtn.2026.103057_bib5","article-title":"C2c2 is a single-component programmable RNA-guided RNA-targeting CRISPR effector","volume":"353","author":"Abudayyeh","year":"2016","journal-title":"Science"},{"key":"10.1016\/j.omtn.2026.103057_bib6","first-page":"1019","article-title":"RNA editing with CRISPR-Cas13","volume":"358","author":"Cox","year":"2017","journal-title":"Science"},{"key":"10.1016\/j.omtn.2026.103057_bib7","first-page":"665","article-title":"Transcriptome engineering with RNA-targeting type VI-D CRISPR effectors","volume":"173","author":"Konermann","year":"2018","journal-title":"Cell"},{"key":"10.1016\/j.omtn.2026.103057_bib8","first-page":"280","article-title":"RNA targeting with CRISPR\u2013Cas13","volume":"550","author":"Abudayyeh","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.omtn.2026.103057_bib9","first-page":"635","article-title":"Expression profiling reveals off-target gene regulation by RNAi","volume":"21","author":"Jackson","year":"2003","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.omtn.2026.103057_bib10","first-page":"1179","article-title":"Widespread siRNA \u201coff-target\u201d transcript silencing mediated by seed region sequence complementarity","volume":"12","author":"Jackson","year":"2006","journal-title":"RNA"},{"key":"10.1016\/j.omtn.2026.103057_bib11","first-page":"199","article-title":"3\u2032 UTR seed matches, but not overall identity, are associated with RNAi off-targets","volume":"3","author":"Birmingham","year":"2006","journal-title":"Nat. Methods"},{"key":"10.1016\/j.omtn.2026.103057_bib12","first-page":"1056","article-title":"Cas13d knockdown of lung protease Ctsl prevents and treats SARS-CoV-2 infection","volume":"18","author":"Cui","year":"2022","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.omtn.2026.103057_bib13","first-page":"27","article-title":"An RNA-targeting CRISPR\u2013Cas13d system alleviates disease-related phenotypes in Huntington\u2019s disease models","volume":"26","author":"Morelli","year":"2023","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.omtn.2026.103057_bib14","first-page":"6492","article-title":"Mitigating a TDP-43 proteinopathy by targeting ataxin-2 using RNA-targeting CRISPR effector proteins","volume":"14","author":"Zeballos C","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.omtn.2026.103057_bib15","first-page":"835","article-title":"CasRx-mediated RNA targeting prevents choroidal neovascularization in a mouse model of age-related macular degeneration","volume":"7","author":"Zhou","year":"2020","journal-title":"Natl. Sci. Rev."},{"key":"10.1016\/j.omtn.2026.103057_bib16","first-page":"518","article-title":"Modulation of metabolic functions through Cas13d-mediated gene knockdown in liver","volume":"11","author":"He","year":"2020","journal-title":"Protein Cell"},{"key":"10.1016\/j.omtn.2026.103057_bib17","article-title":"Targeted gene silencing in the nervous system with CRISPR-Cas13","volume":"8","author":"Powell","year":"2022","journal-title":"Sci. Adv."},{"key":"10.1016\/j.omtn.2026.103057_bib18","first-page":"270","article-title":"Two distinct RNase activities of CRISPR-C2c2 enable guide-RNA processing and RNA detection","volume":"538","author":"East-Seletsky","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.omtn.2026.103057_bib19","first-page":"241","article-title":"Cas13-induced cellular dormancy prevents the rise of CRISPR-resistant bacteriophage","volume":"570","author":"Meeske","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.omtn.2026.103057_bib20","first-page":"714","article-title":"The molecular architecture for RNA-guided RNA cleavage by Cas13a","volume":"170","author":"Liu","year":"2017","journal-title":"Cell"},{"key":"10.1016\/j.omtn.2026.103057_bib21","first-page":"e65","article-title":"CRISPR\/Cas13 effectors have differing extents of off-target effects that limit their utility in eukaryotic cells","volume":"50","author":"Ai","year":"2022","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.omtn.2026.103057_bib22","first-page":"334","article-title":"Collateral activity of the CRISPR\/RfxCas13d system in human cells","volume":"6","author":"Shi","year":"2023","journal-title":"Commun. Biol."},{"key":"10.1016\/j.omtn.2026.103057_bib23","first-page":"20","article-title":"The collateral activity of RfxCas13d can induce lethality in a RfxCas13d knock-in mouse model","volume":"24","author":"Li","year":"2023","journal-title":"Genome Biol."},{"key":"10.1016\/j.omtn.2026.103057_bib24","article-title":"Negative autoregulation mitigates collateral RNase activity of repeat-targeting CRISPR-Cas13d in mammalian cells","volume":"40","author":"Kelley","year":"2022","journal-title":"Cell Rep."},{"key":"10.1016\/j.omtn.2026.103057_bib25","first-page":"64","article-title":"Precise RNA targeting with CRISPR\u2013Cas13d","volume":"44","author":"Hart","year":"2026","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.omtn.2026.103057_bib26","first-page":"781","article-title":"Approaches to improving the kinetics of adenovirus-delivered genes and gene products","volume":"57","author":"Xu","year":"2005","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.omtn.2026.103057_bib27","article-title":"Novel vectors and approaches for gene therapy in liver diseases","volume":"3","author":"Maestro","year":"2021","journal-title":"JHEP Rep."},{"key":"10.1016\/j.omtn.2026.103057_bib28","first-page":"618","article-title":"Cas13b is a Type VI-B CRISPR-associated RNA-guided RNase differentially regulated by accessory proteins Csx27 and Csx28","volume":"65","author":"Smargon","year":"2017","journal-title":"Mol. Cell"},{"key":"10.1016\/j.omtn.2026.103057_bib29","first-page":"499","article-title":"Programmable RNA editing with compact CRISPR\u2013Cas13 systems from uncultivated microbes","volume":"18","author":"Xu","year":"2021","journal-title":"Nat. Methods"},{"key":"10.1016\/j.omtn.2026.103057_bib30","first-page":"177","article-title":"Intrinsic targeting of host RNA by Cas13 constrains its utility","volume":"8","author":"Li","year":"2024","journal-title":"Nat. Biomed. Eng."},{"key":"10.1016\/j.omtn.2026.103057_bib31","article-title":"Suppression of leaky expression of adenovirus genes by insertion of microRNA-targeted sequences in the replication-incompetent adenovirus vector genome","volume":"1","author":"Shimizu","year":"2014","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.omtn.2026.103057_bib32","first-page":"1","article-title":"Efficient generation of adenovirus vectors carrying the CRISPR-Cas12a system by suppressing Cas12a expression in packaging cells","volume":"304","author":"Tsukamoto","year":"2019","journal-title":"J. Biotechnol."},{"key":"10.1016\/j.omtn.2026.103057_bib33","first-page":"1430","article-title":"Quantitative analysis of the leaky expression of adenovirus genes in cells transduced with a replication-incompetent adenovirus vector","volume":"8","author":"Shimizu","year":"2011","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.omtn.2026.103057_bib34","first-page":"8902","article-title":"Persistence of recombinant adenovirus in vivo is not dependent on vector DNA replication","volume":"71","author":"Nelson","year":"1997","journal-title":"J. Virol."},{"key":"10.1016\/j.omtn.2026.103057_bib35","article-title":"Human adenovirus type 5 vectors deleted of early region 1 (E1) undergo limited expression of early replicative E2 proteins and DNA replication in non-permissive cells","volume":"12","author":"Saha","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.omtn.2026.103057_bib36","first-page":"339","article-title":"Restricted replication of human adenovirus type 5 in mouse cell lines","volume":"14","author":"Blair","year":"1989","journal-title":"Virus Res."},{"key":"10.1016\/j.omtn.2026.103057_bib37","first-page":"285","article-title":"Development of an adenovirus vector lacking the expression of virus-associated RNAs","volume":"154","author":"Machitani","year":"2011","journal-title":"J. Controlled Release"},{"key":"10.1016\/j.omtn.2026.103057_bib38","first-page":"537","article-title":"Fatality in mice due to oversaturation of cellular microRNA\/short hairpin RNA pathways","volume":"441","author":"Grimm","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.omtn.2026.103057_bib39","first-page":"2995","article-title":"Secreted PCSK9 decreases the number of LDL receptors in hepatocytes and in livers of parabiotic mice","volume":"116","author":"Lagace","year":"2006","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.omtn.2026.103057_bib40","first-page":"2069","article-title":"Overexpression of PCSK9 accelerates the degradation of the LDLR in a post-endoplasmic reticulum compartment","volume":"102","author":"Maxwell","year":"2005","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.omtn.2026.103057_bib41","first-page":"11915","article-title":"Therapeutic RNAi targeting PCSK9 acutely lowers plasma cholesterol in rodents and LDL cholesterol in nonhuman primates","volume":"105","author":"Frank-Kamenetsky","year":"2008","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.omtn.2026.103057_bib42","first-page":"9820","article-title":"A proprotein convertase subtilisin\/kexin type 9 neutralizing antibody reduces serum cholesterol in mice and nonhuman primates","volume":"106","author":"Chan","year":"2009","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.omtn.2026.103057_bib43","first-page":"265","article-title":"Regulation of cholesterol homeostasis in health and diseases: from mechanisms to targeted therapeutics","volume":"7","author":"Duan","year":"2022","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.omtn.2026.103057_bib44","article-title":"SEC24A deficiency lowers plasma cholesterol through reduced PCSK9 secretion","volume":"2","author":"Chen","year":"2013","journal-title":"eLife"},{"key":"10.1016\/j.omtn.2026.103057_bib45","article-title":"Hepatic inactivation of murine Surf4 results in marked reduction in plasma cholesterol","volume":"11","author":"Tang","year":"2022","journal-title":"eLife"},{"key":"10.1016\/j.omtn.2026.103057_bib46","first-page":"375","article-title":"Clinical Chemistry Reference Intervals for C57BL\/6J, C57BL\/6N, and C3HeB\/FeJ Mice (Mus musculus)","volume":"55","author":"Otto","year":"2016","journal-title":"J. Am. Assoc. Lab. Anim. Sci."},{"key":"10.1016\/j.omtn.2026.103057_bib47","article-title":"Sumoylation of Cas9 at lysine 848 regulates protein stability and DNA binding","volume":"5","author":"Erg\u00fcnay","year":"2022","journal-title":"Life Sci. Alliance"},{"key":"10.1016\/j.omtn.2026.103057_bib48","first-page":"41","article-title":"A highly durable RNAi therapeutic inhibitor of PCSK9","volume":"376","author":"Fitzgerald","year":"2017","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.omtn.2026.103057_bib49","first-page":"1430","article-title":"Inclisiran in patients at high cardiovascular risk with elevated LDL cholesterol","volume":"376","author":"Ray","year":"2017","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.omtn.2026.103057_bib50","first-page":"1520","article-title":"Inclisiran for the treatment of Heterozygous Familial Hypercholesterolemia","volume":"382","author":"Raal","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.omtn.2026.103057_bib51","first-page":"108","article-title":"High-fidelity Cas13 variants for targeted RNA degradation with minimal collateral effects","volume":"41","author":"Tong","year":"2023","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.omtn.2026.103057_bib52","first-page":"460","article-title":"A high-fidelity CRISPR-Cas13 system improves abnormalities associated with C9ORF72-linked ALS\/FTD","volume":"16","author":"McCallister","year":"2025","journal-title":"Nat. Commun."},{"key":"10.1016\/j.omtn.2026.103057_bib53","first-page":"410","article-title":"Adenovirus vector\u2013induced IL-6 promotes leaky adenoviral gene expression, leading to acute hepatotoxicity","volume":"206","author":"Shimizu","year":"2021","journal-title":"J. Immunol."},{"key":"10.1016\/j.omtn.2026.103057_bib54","first-page":"278","article-title":"Toxicity and adaptive immune response to intracellular transgenes delivered by helper-dependent vs. first generation adenoviral vectors","volume":"84","author":"Mian","year":"2005","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.omtn.2026.103057_bib55","first-page":"63","article-title":"Sustained human factor VIII expression in hemophilia A mice following systemic delivery of a gutless adenoviral vector","volume":"5","author":"Reddy","year":"2002","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omtn.2026.103057_bib56","first-page":"357","article-title":"Improving adenovirus vector-mediated RNAi efficiency by lacking the expression of virus-associated RNAs","volume":"178","author":"Machitani","year":"2013","journal-title":"Virus Res."},{"key":"10.1016\/j.omtn.2026.103057_bib57","first-page":"1690","article-title":"Expression of coxsackie and adenovirus receptor reduces the lung metastatic potential of murine tumor cells","volume":"121","author":"Yamashita","year":"2007","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.omtn.2026.103057_bib58","first-page":"805","article-title":"CRISPR-Cas13d induces efficient mRNA knockdown in animal embryos","volume":"54","author":"Kushawah","year":"2020","journal-title":"Dev. Cell"},{"key":"10.1016\/j.omtn.2026.103057_bib59","first-page":"2013","article-title":"A simple method for constructing E1- and E1\/E4-deleted recombinant adenoviral vectors","volume":"10","author":"Mizuguchi","year":"1999","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.omtn.2026.103057_bib60","first-page":"149","article-title":"An effective gene-knockdown using multiple shRNA-expressing adenovirus vectors","volume":"153","author":"Motegi","year":"2011","journal-title":"J. Controlled Release"},{"key":"10.1016\/j.omtn.2026.103057_bib61","first-page":"912","article-title":"Downregulation of human CD46 by adenovirus serotype 35 vectors","volume":"14","author":"Sakurai","year":"2007","journal-title":"Gene Ther."},{"key":"10.1016\/j.omtn.2026.103057_bib62","first-page":"730","article-title":"A simplified system for constructing recombinant adenoviral vectors containing heterologous peptides in the HI loop of their fiber knob","volume":"8","author":"Mizuguchi","year":"2001","journal-title":"Gene Ther."},{"key":"10.1016\/j.omtn.2026.103057_bib63","first-page":"2577","article-title":"Efficient construction of a recombinant adenovirus vector by an improved in vitro ligation method","volume":"9","author":"Mizuguchi","year":"1998","journal-title":"Hum. Gene Ther."}],"container-title":["Molecular Therapy Nucleic Acids"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2162253126002283?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2162253126002283?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T15:09:36Z","timestamp":1788880176000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2162253126002283"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":63,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["S2162253126002283"],"URL":"https:\/\/doi.org\/10.1016\/j.omtn.2026.103057","relation":{},"ISSN":["2162-2531"],"issn-type":[{"value":"2162-2531","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Adenovirus vector-mediated delivery of the CRISPR-CasRx system enables gene knockdown with suppressed collateral activity","name":"articletitle","label":"Article Title"},{"value":"Molecular Therapy Nucleic Acids","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.omtn.2026.103057","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Inc. on behalf of The American Society of Gene and Cell Therapy.","name":"copyright","label":"Copyright"}],"article-number":"103057"}}